Abstract:CSB (Cockayne syndrome group B) and SMARCAL1 (SWI/SNF-related, matrix-associated, actin-dependent, regulator of chromatin, subfamily A-like 1) are DNA translocases that belong to the SNF2 helicase family. They both are enriched at stalled replication forks. While SMARCAL1 is recruited by RPA32 to stalled forks, little is known about whether RPA32 also regulates CSB's association with stalled forks. Here, we report that CSB directly interacts with RPA, at least in part via a RPA32C-interacting motif within the N-terminal region of CSB. Modeling of the CSB-RPA32C interaction suggests that CSB binds the RPA32C surface previously shown to be important for binding of UNG2 and SMARCAL1. We show that this interaction is necessary for promoting fork slowing and fork degradation in BRCA2-deficient cells but dispensable for mediating restart of stalled forks. CSB competes with SMARCAL1 for RPA32 at stalled forks and acts non-redundantly with SMARCAL1 to restrain fork progression in response to mild replication stress. In contrast to CSB stimulated restart of stalled forks, SMARCAL1 inhibits restart of stalled forks in BRCA2-deficient cells, likely by suppressing BIR-mediated repair of collapsed forks. Loss of CSB leads to re-sensitization of SMARCAL1-depleted BRCA2-deficient cells to chemodrugs, underscoring a role of CSB in targeted cancer therapy.

What problem does this paper attempt to address?

The paper primarily explores the regulatory roles of CSB (Cockayne syndrome group B protein) and SMARCAL1 in the fate of stalled replication forks in BRCA2-deficient cells and the competitive relationship between them. Specifically, the study addresses the following key issues: 1. **Interaction between CSB and RPA**: The study found that CSB can directly interact with RPA (Replication Protein A), and this interaction is at least partially mediated by a specific RPA32 binding motif within the N-terminal region of CSB. 2. **Competition between CSB and SMARCAL1**: Both CSB and SMARCAL1 can bind to RPA32 at stalled replication forks, but they compete with each other. CSB promotes the slowing and degradation of replication forks through its binding to RPA32, especially in BRCA2-deficient cells. 3. **Different regulatory mechanisms on stalled replication forks**: CSB and SMARCAL1 play different roles in regulating the fate of stalled replication forks. CSB promotes the restart of stalled replication forks, while SMARCAL1 inhibits this process, possibly by suppressing the break-induced replication (BIR) pathway to repair collapsed replication forks. 4. **Potential role of CSB in targeted cancer therapy**: The study also found that the loss of CSB increases the sensitivity of BRCA2-deficient cells to chemotherapeutic drugs when SMARCAL1 is depleted, suggesting the potential application value of CSB in cancer treatment. In summary, this paper delves into the mechanisms of action of CSB and SMARCAL1 in the response to replication stress, revealing their significant functional differences in regulating the fate of stalled replication forks. It provides new insights into the stability and repair mechanisms of replication forks and lays the foundation for further development of therapeutic strategies targeting BRCA2-deficient tumors.

CSB and SMARCAL1 compete for RPA32 at stalled forks and differentially control the fate of stalled forks in BRCA2-deficient cells